simendan has been researched along with ng-nitroarginine methyl ester in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caimmi, PP; Grossini, E; Molinari, C; Teodori, G; Vacca, G | 1 |
| Böttiger, BW; Motsch, J; Rauch, H | 1 |
| Caimmi, PP; Grossini, E; Molinari, C; Uberti, F; Vacca, G | 1 |
| Bellomo, G; Caimmi, P; Grossini, E; Mary, D; Molinari, C; Pollesello, P; Vacca, G; Valente, G | 1 |
| Bellofatto, K; Farruggio, S; Grossini, E; Mary, DA; Mombello, C; Origlia, V; Pollesello, P; Sigaudo, L; Vacca, G; Valente, G | 1 |
1 review(s) available for simendan and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Newer approaches to the pharmacological management of heart failure.
Topics: Calcium Signaling; Cardiotonic Agents; Cardiovascular Agents; Endothelins; Enzyme Inhibitors; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridazines; Pyridines; Simendan; Tetrazoles | 2006 |
4 other study(ies) available for simendan and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig.
Topics: Anesthesia; Animals; Autonomic Nervous System; Blood Gas Analysis; Coronary Circulation; Coronary Vessels; Enzyme Inhibitors; Hemodynamics; Hydrazones; Infusions, Intravenous; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyridazines; Simendan; Swine; Vasodilator Agents | 2005 |
Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel.
Topics: Adenylyl Cyclase Inhibitors; Animals; Cells, Cultured; Coronary Vessels; Cyclic AMP; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hydrazones; In Vitro Techniques; Ion Channel Gating; KATP Channels; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyridazines; Simendan; Swine; Vasodilator Agents | 2009 |
Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.
Topics: Acute Kidney Injury; Animals; Antioxidants; Apoptosis; Cell Survival; Decanoic Acids; Glucose; Hydrazones; Hydroxy Acids; KATP Channels; Kidney; Mannitol; Mitochondria; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Potassium Chloride; Procaine; Pyridazines; Reperfusion Injury; Simendan; Swine | 2012 |
Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats.
Topics: Anesthesia; Animals; Apoptosis; bcl-2-Associated X Protein; Biopsy; Blood Flow Velocity; Caspase 3; Cell Survival; Decanoic Acids; Glutathione; Hydrazones; Hydroxy Acids; Liver; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphodiesterase Inhibitors; Portal Vein; Potassium Channels; Pyridazines; Rats; Reperfusion Injury; Simendan; Thiobarbituric Acid Reactive Substances | 2014 |